COVACEUSZACH, SONIA
 Distribuzione geografica
Continente #
AS - Asia 1.570
NA - Nord America 995
EU - Europa 322
SA - Sud America 306
AF - Africa 31
OC - Oceania 1
Totale 3.225
Nazione #
US - Stati Uniti d'America 934
SG - Singapore 649
CN - Cina 375
BR - Brasile 236
HK - Hong Kong 167
VN - Vietnam 156
FR - Francia 82
KR - Corea 75
IT - Italia 67
NL - Olanda 61
AR - Argentina 35
BD - Bangladesh 33
IN - India 26
CA - Canada 25
GB - Regno Unito 25
JP - Giappone 21
DE - Germania 17
FI - Finlandia 16
MX - Messico 14
ZA - Sudafrica 13
EC - Ecuador 12
TR - Turchia 12
IL - Israele 11
ID - Indonesia 10
CL - Cile 7
ES - Italia 7
PL - Polonia 7
VE - Venezuela 7
AT - Austria 6
IQ - Iraq 6
MA - Marocco 6
UA - Ucraina 6
PK - Pakistan 5
EG - Egitto 4
HN - Honduras 4
JM - Giamaica 4
RU - Federazione Russa 4
SE - Svezia 4
CO - Colombia 3
EE - Estonia 3
KZ - Kazakistan 3
PH - Filippine 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
PT - Portogallo 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MQ - Martinica 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TG - Togo 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.225
Città #
Singapore 378
Santa Clara 252
Hefei 183
Dallas 169
Hong Kong 164
Beijing 77
Ashburn 75
Seoul 75
Ho Chi Minh City 67
San Jose 67
Lauterbourg 65
Los Angeles 51
Hanoi 39
Amsterdam 27
São Paulo 22
New York 16
Trieste 15
Tokyo 11
Lappeenranta 10
Milan 10
Rio de Janeiro 10
Bengaluru 9
Buffalo 9
Minamishinagawa 9
Brasília 8
Orem 8
Curitiba 7
Frankfurt am Main 7
Houston 7
Johannesburg 7
Helsinki 6
Porto Alegre 6
Rome 6
Biên Hòa 5
Brooklyn 5
Buenos Aires 5
Chennai 5
Haiphong 5
London 5
Montreal 5
Quito 5
Sorocaba 5
Warsaw 5
Da Nang 4
Denver 4
Guayaquil 4
Las Vegas 4
Manchester 4
Nuremberg 4
Portsmouth 4
Santiago 4
Stockholm 4
Vienna 4
Atibaia 3
Atlanta 3
Belo Horizonte 3
Boardman 3
Campinas 3
Caracas 3
Chicago 3
Dhaka 3
Fortaleza 3
Groningen 3
Istanbul 3
Manila 3
Mexico City 3
Newark 3
Philadelphia 3
Piscataway 3
Quilmes 3
São Bernardo do Campo 3
Tallinn 3
Toronto 3
Acalanes Ridge 2
Albuquerque 2
Arapiraca 2
Athens 2
Baghdad 2
Bangkok 2
Brampton 2
Bristol 2
Bình Dương 2
Bắc Giang 2
Cairo 2
Carapicuíba 2
Cavallino 2
Chandigarh 2
Coro 2
Council Bluffs 2
Crawfordville 2
Dakar 2
Delton 2
Dourados 2
Duque de Caxias 2
Durban 2
Düsseldorf 2
Elk Grove Village 2
Florence 2
Florianópolis 2
Gainesville 2
Totale 2.076
Nome #
Unveiling the Solvent Effect: DMSO Interaction with Human Nerve Growth Factor and Its Implications for Drug Discovery 220
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 111
LuxR Solos in the Plant Endophyte Kosakonia sp. Strain KO348 96
Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody 77
X-Ray Diffraction @ Elettra Synchrotron: Atomic Insight Of Your Biomedical Target. 72
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria 69
Covalent immobilization of delipidated human serum albumin on poly(pyrrole-2-carboxylic) acid film for the impedimetric detection of perfluorooctanoic acid 68
ATP binding to the Nerve Growth Factor: a molecular switch for neurotrophins signaling? 65
Distinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg2+ 64
Do fats matter? Design of serum albumin bioreceptor for PFOA, from toxicological studies to biosensor applications 63
A Spectroscopic Study on the Amyloid‐β Interaction with Clicked Peptide‐Porphyrin Conjugates: a Vision Toward the Detection of Aβ Peptides in Aqueous Solution 62
The binding of ATP to the Nerve Growth Factor: a new mechanism for neurotrophins signaling. 61
Structural and functional properties of mouse proNGF 57
Molecular and structural basis of dystroglycanopathies 57
Axe7A: A novel CE7 Acetylxylan esterase found in rumen bacterium Prevotella ruminicola 23. 57
Structural determinants for the molecular promiscuity of mouse proNGF 56
Endogenous modulators of neurotrophin signaling: Landscape of the transient ATP-NGF interactions 56
A primary dystroglycanopathy causing muscle-eye-brain disease with multicystic leukodystrophy: from cellular and biochemical analysis to a mouse model 55
LuxR Solos from Environmental Fluorescent Pseudomonads 54
Structural flexibility of human ?lpha-dystroglycan 53
A combined evolutionary and structural approach to disclose the primary structural determinants essential for proneurotrophins biological functions 53
The NGF R100W Mutation, Associated with Hereditary Sensory Autonomic Neuropathy Type V, Specifically Affects the Binding Energetic Landscapes of NGF and of Its Precursor proNGF and p75NTR 52
Synchrotron Radiation as a tool for the investigation of the structural basis of primary dystroglycanopathies. 51
In vitro receptor binding properties of a painless NGF mutein, linked to Hereditary Sensory Autonomic Neuropathy type V 50
Untangling the Conformational Plasticity of V66M Human proBDNF Polymorphism as a Modifier of Psychiatric Disorder Susceptibility 50
A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. 50
The molecular basis of alpha-Dystroglycan hypoglycosylation: a crystallographic and SAXS study 49
Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity 48
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of ?-dystroglycan 47
Unveiling the binding mode of perfluorooctanoic acid to human serum albumin 47
Structural flexibility of human alpha-dystroglycan 47
Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis 46
Molecular architecture of the glycogen- committed PP1/PTG holoenzyme. 44
Quorum sensing signaling studies in Pseudomonas syringae pv. actinidae 44
The Conundrum of the High-Affinity NGF Binding Site Formation Unveiled? 43
Axe7A: A Novel CE7 Acetylxylan Esterase for Biomass Degradation. 42
Insights into the Nerve Growth Factor / endogenous ligands binding mechanism. 40
Negative Regulation of Violacein Biosynthesis in Chromobacterium violaceum 38
Enzymatic systems with some potentials in biocatalysis 38
Conformational rigidity within plasticity promotes differential target recognition of Nerve Growth Factor 37
Purification, crystallization and preliminary X-ray analysis of the Fab fragment from MNAC13, a novel antagonistic anti- 36
Identification of a new small Rho GTPase inhibitor effective in glioblastoma human cells 36
Towards a comprehension of the structure of mouse proNGF 34
The structure of the T190M mutant of murine ?-dystroglycan at high resolution: insight into the molecular basis of a primary dystroglycanopathy 34
Intrinsic structural disorder of mouse proNGF 34
Unraveling the binding mode of the neutralizing neuroantibody aD11 to NGF 34
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 33
METHOD FOR THE HUMANIZATION OF ANTIBODIES AND HUMANIZED ANTIBODIES THEREBY OBTAINED 32
Taking Pain Out of NGF: A "Painless" NGF Mutant, Linked to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic Activity 32
Intrinsic structural disorder of mouse proNGF 32
The molecular basis of ?-dystroglycan hypoglycosylation: a crystallographic and SAXS study 32
The Kiwifruit Emerging Pathogen Pseudomonas syringae pv. actinidiae Does Not Produce AHLs but Possesses Three LuxR Solos 31
The molecular basis of alpha-dystroglycan hypoglycosylation: a crystallographic and SAXS study 31
Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody 30
Purification, crystallization, X-ray diffraction analysis and phasing of a Fab fragment of monoclonal neuroantibody alphaD11 against nerve growth factor. 29
The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. 29
Structural and functional properties of mouse proNGF 27
Novel recombinant antibodies against AD biomarkers linked to neurotrophin signalling as potential diagnostic tools 27
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 27
Functional and structural study of the dimeric inner membrane protein SbmA 27
Insights into the structure of the N-terminal region of alpha-dystroglycan: a concerted crystallographic and SAXS study 26
Insights into the structure and function of mouse proNGF 26
Live cell optical super-resolution microscopy of dystroglycan mutants as a model for dystroglycanopathies in multiple cell lines 26
Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: A structural insight. 26
Structural basis for the selectivity of recombinant mouse short proNGF versus NGF towards its binding partners. 26
Towards an understanding of the structure and dynamic of mouse proNGF 26
Remarkable analgesic effects of an anti-NGF monoclonal antibody with function neutralizing properties 25
A humanized anti-NGF antibody with analgesic properties 25
Structural Insights into a Novel Interkingdom Signaling Circuit by Cartography of the Ligand-Binding Sites of the Homologous QuorumSensing LuxR-Family 24
Studies on synthetic LuxR solo hybrids 24
Insights into the structure of the N-terminal region of ?-dystroglycan: a concerted crystallographic and SAXS study 23
Humanization of therapeutic neutralizing antibodies with analgesic effects 20
Totale 3.313
Categoria #
all - tutte 10.577
article - articoli 6.479
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 0 1 0 3 0
2024/20251.080 1 19 87 38 213 80 9 79 42 42 252 218
2025/20262.124 113 260 403 305 332 113 238 69 67 102 65 57
2026/2027105 105 0 0 0 0 0 0 0 0 0 0 0
Totale 3.313